POTENT VASOCONSTRICTOR EFFECTS AND CLEARANCE OF ENDOTHELIN IN THE HUMAN FOREARM

被引:39
作者
PERNOW, J [1 ]
HEMSEN, A [1 ]
LUNDBERG, JM [1 ]
NOWAK, J [1 ]
KAIJSER, L [1 ]
机构
[1] HUDDINGE HOSP, PHYSIOL CLIN, S-14186 HUDDINGE, SWEDEN
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 1991年 / 141卷 / 03期
关键词
ENDOTHELIN; FOREARM; HUMAN; NORADRENALINE; PROSTACYCLIN; VASCULAR RESISTANCE; VASOCONSTRICTION; VENOUS COMPLIANCE;
D O I
10.1111/j.1748-1716.1991.tb09087.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The vascular effects of endothelin-1 in humans were investigated by infusion into the brachial artery of healthy volunteers. Endothelin-1 (5-500 pmol min-1) evoked potent and long lasting increase in forearm vascular resistance (FVR) and reduction in venous compliance, suggesting constriction of both resistance and capacitance vessels. The threshold for effect on forearm vascular resistance was at a calculated plasma concentration of 614 pmol 1(-1). Endothelin-1 was on a molar basis 10-20 times more potent than noradrenaline as constrictor of both resistance and capacitance vessels. The increase in forearm vascular resistance induced by endothelin-1 lasted more than 30 min and that by noradrenaline less than 3 minutes. The endothelin-1-like immunoreactivity collected in the venous effluent during the infusion was 10-26% of the calculated arterial plasma concentration, indicating local removal of endothelin. After the infusion of endothelin-1 the urine concentration of prostacyclin metabolite increased significantly, indicating release of prostacyclin, whereas the concentration of thromboxane metabolite did not increase. It is concluded that endothelin-1 is a highly potent constrictor of human resistance and capacitance vessels, that it causes release of prostacyclin and that circulating endothelin-1 is efficiently removed by the forearm in vivo.
引用
收藏
页码:319 / 324
页数:6
相关论文
共 27 条
[1]   IMMUNOREACTIVE ENDOTHELIN IN HUMAN-PLASMA - MARKED ELEVATIONS IN PATIENTS IN CARDIOGENIC-SHOCK [J].
CERNACEK, P ;
STEWART, DJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :562-567
[2]  
DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797
[3]  
FitzGerald G A, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P87
[4]   RAISED PLASMA ENDOTHELIN-I CONCENTRATION FOLLOWING COLD PRESSOR TEST [J].
FYHRQUIST, F ;
SAIJONMAA, O ;
METSARINNE, K ;
TIKKANEN, I ;
ROSENLOF, K ;
TIKKANEN, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 169 (01) :217-221
[5]   UNTERSUCHUNGEN UBER EIGENSCHAFTEN UND VERWENDUNGSMOGLICHKEITEN EINES FLEXIBLEN EXTREMITATENPLETHYSMOGRAFEN [J].
GRAF, K ;
WESTERSTEN, A .
ACTA PHYSIOLOGICA SCANDINAVICA, 1959, 46 (01) :1-18
[6]   EFFECTS OF ENDOTHELIN ON REGIONAL HEMODYNAMICS IN CONSCIOUS RATS [J].
HAN, SP ;
TRAPANI, AJ ;
FOK, KF ;
WESTFALL, TC ;
KNUEPFER, MM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 159 (03) :303-305
[7]   CELLULAR MECHANISM OF ACTION BY A NOVEL VASOCONSTRICTOR ENDOTHELIN IN CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
HIRATA, Y ;
YOSHIMI, H ;
TAKATA, S ;
WATANABE, TX ;
KUMAGAI, S ;
NAKAJIMA, K ;
SAKAKIBARA, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (03) :868-875
[8]  
HJEMDAHL P, 1987, METHOD ENZYMOL, V142, P521
[9]   HUMAN VASCULAR-RESPONSES TO ENDOTHELIN-1 - OBSERVATIONS INVIVO AND INVITRO [J].
HUGHES, AD ;
THOM, SAM ;
WOODALL, N ;
SCHACHTER, M ;
HAIR, WM ;
MARTIN, GN ;
SEVER, PS .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 :S225-S228
[10]   THE HUMAN ENDOTHELIN FAMILY - 3 STRUCTURALLY AND PHARMACOLOGICALLY DISTINCT ISOPEPTIDES PREDICTED BY 3 SEPARATE GENES [J].
INOUE, A ;
YANAGISAWA, M ;
KIMURA, S ;
KASUYA, Y ;
MIYAUCHI, T ;
GOTO, K ;
MASAKI, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2863-2867